Methyl palmitate inhibits lipopolysaccharide-stimulated phagocytic activity of rat peritoneal macrophages

Journal of Biochemical and Molecular Toxicology

Volumn 20, Issue 6, 2006, Pages 302-308

  Sarkar, Swapna ^a   Khan, M Firoze ^a   Kaphalia, Bhupendra S ^a   Ansari, G A S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Methyl Palmitate; Peritoneal Macrophages; Phagocytosis

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PALMITIC ACID METHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNE SYSTEM; KUPFFER CELL; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; RAT;

ANIMALS; CELL SEPARATION; CELL SURVIVAL; CYCLOOXYGENASE 2; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICROSPHERES; NITRITES; PALMITATES; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845884313     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20150     Document Type: Article

References (44)

1. Lough AK, Felinski L, Garton GA. The production of methyl esters of fatty acids as artifacts during the extraction of storage of tissue lipids in the presence of methanol. J Lipid Res 1962;3:478-479.
2. Schmidt A, Vogel R, Witherup KM, Rutledge SJ, Pitzenberger SM, Adam M, Rodan GA. Identification of fatty acid methyl esters as naturally occurring transcriptional regulators of the members of the peroxisome proliferator- activated receptor family. Lipids 1996;31:1115-1124.
3. Kaphalia BS, Carr JB, Ansari GAS. Increased endobiotic fatty acid methyl esters following exposure to methanol. Fundam Appl Toxicol 1995;28:264-273.
4. Kaphalia BS, Green SM, Ansari GAS. Fatty acid ethyl and methyl ester synthases, and fatty acid anilide synthase in HepG2 and AR42J cells: Interrelationships and inhibition by tri-o-tolyl phosphate. Toxicol Appl Pharmacol 1999;159:134-141.
5. Mericle KA, Kaphalia BS, Ansari GAS. Modulation of fatty acid methyl esters in the rats pre-treated with tri-o-tolyl phosphate. J Toxicol Environ Health 2004;67:583-593.
6. Rentsch M, Puelimann K, Sirek S, Lesalnieks I, Kienle K, Mueller T, Bolder U, Geissler E, Jauch KW, Beham A. Benefit of Kupffer cell modulation with glycine versus Kupffer cell depletion after liver transplantation in the rat: Effects on postischemic reperfusion injury, apoptotic cell death graft regeneration and survival. Transplant Int 2005;18:1079-1089.
7. Cai P, Kaphalia BS, Ansari GAS. Methyl palmitate: Inhibitor of phagocytosis in primary rat Kupffer cells. Toxicology 2005;210:197-204.
8. DiLuzio NR, Wooles WR, Depression of phagocytic activity and immune response by methyl palmitate. Am J Physiol 1964;206:939-943.
9. AlTuwaiijri A, Akdamar K, Di Luzio NR. Modification of galactosamine-induced liver injury in rats by reticuloendothelial system stimulation or depression. Hepatology 1981;1:107-113.
10. Marzi I, Cowper K, Takei Y, Lindert K, Lemasters JJ, Thurman RG. Methyl palmitate prevents Kupffer cell activation and improves survival after orthotopic liver transplantation in the rat. Transplant Int 1991;4:215-220.
11. Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133-2143.
12. Rose ML, Gremolec DR, Schoonhoven R, Thurman RG. Kupffer cells are casually responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 1997;18:1453-1456.
13. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV. Molecular recognition of fatty acids by peroxisome proliferators-activated receptors. Mol Cell 1999;3:397-403.
14. Lehnert BE. Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect 1992;97:17-46.
15. Gjomarkaj M, Pace E, Melis M, Spatafora M, Toews GB. Mononuclear cells in exudative malignant pleural effusions: Characterization of pleural phagocytic cells. Chest 1994;106:1042-1049.
16. Chen LY, Zuraw BL, Zhao M, Liu FT, Huang S, Pan ZK. Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kB activation in human peripheral blood monocytes. Am J Physiol Lung Cell Mol Physiol 2003;284:L607-L613.
17. Chen ZT, Li SL, Cai EQ, Wu WL, Jin JS, Zhu B. LPS induces pulmonary intravascular macrophages producing inflammatory mediators via activating NF-kappa-B. J Cell Biochem 2003;89:1206-1214.
18. 38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol 2003;170:6244-6249.
19. Chen F, Sun SC, Kuhn DC, Graydos LJ, Dermers LM. Essential role of NF-kB activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 1995;214:985-992.
20. Christman JW, Sadikot RT, Blackwell TS, The role of nuclear factor-kB in pulmonary diseases. Chest 2000;117:1482-1487.
21. Chen F, Castranova V, Shi X, Demer LM. New insights into the role of nuclear factor-kB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999;45:7-17.
22. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995;268:813-819.
23. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 1995;96:2339-2347.
24. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994;24:1167-1171.
25. Chang KP, Dwyer DM. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. Science 1976;193:678-680.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:263-275.
27. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987;80:1550-1560.
28. Valledor AF, Ricote M. Nuclear receptor signaling in macrophages. Biochem Pharmacol 2004;67:201-212.
29. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med 2001;29:S16-S18.
30. Chang Yi, Chen TL, Sheu JR, Chen MR. Suppressive effects of ketamine on macrophages functions. Toxicol Appl Pharmacol 2005;204:27-35.
31. Woo ER, Lee JY, Cho IJ, Kim SG, Kang KW. Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-kB activation in macrophages. Pharmacol Res 2005;51:539-546.
32. Cowper KB, Currin RT, Dawson TL, Lindert KA, Lemasters JJ, Thurman RG. A new method to monitor Kupffer cell function continuously in the perfused rat liver: Dissociation of glycogenolysis from particle phagocytosis. Biochem J 1990;266:141-147.
33. Kato K, Onodera K, Kato J, Kasai S, Mito M. The immunostimulant OK-432 enhances liver regeneration after 70% hepatectomy. J Hepatol 1995;23:87-94.
34. Kristof AS, Goldberg P, Laubach V, Hussain SN. Role of inducible nitric oxide synthases in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998;158:1883-1889.
35. Nagai H, Kumamoto H, Fukuda M, Takahashi, T. Inducible nitric oxide synthase and apoptosis-related factors in the synovial tissue of temporomandibular joints with internal derangement and osteoarthritis. J Oral Maxillofac Surg 2003;61:801-807.
36. Strunk V, Hahnenkamo K, Schneuing M, Fischer LG, Rich GE Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth Analg 2001;92:681-687.
37. Nishishiro M, Arikawa S, Wakabayashi H, Hashimoto K, Satoh K, Yokoyama K, Unten S, Kakuta H, Kurihara T, Motohashi N, Sakagami H. Inhibition of LPS-stimulated NO production in mouse macrophages-like cells by-azulenequinones. Anticancer Res 2005;25:4157-4163.
38. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
39. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 1997;90:2541-2548.
40. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891.
41. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005;77:3-15.
42. Lowry SF, Calvano SE, and T van der Poll. Measurement of inflammatory mediators in clinical sepsis. In: Sibbald WJ, Vincent JL, editors. Clinical trials for the treatment of sepsis. New York: Springer-Verlag; 1995, pp 86-105.
43. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
44. 2 in guinea pig colonic myenteric ganglia. Am J Physiol 2002;283:G1388-G1397.